Dymaxium Inc. successfully implemented an interactive budget impact model for use with US managed care payers with the Decision Science group from Brystol-Myers Squibb. This model was tailored specifically for the AMCP’s “Format for Formulary Submissions” guidelines. These guidelines have recently been introduced by the Academy of Managed Care Pharmacy in the U.S. to help streamline and standardize formulary submissions.
Some highlights of the Dymaxium model includes enhanced features for full model transparency, advanced budget impact methodology based on historical claims data and predictive switching patterns, and incorporation of 3-D graphing technologies.
“The recently implemented interactive model for our new drug was a very cost - effective product to our company - you continue to present a high-quality, user friendly, interface tools with relatively low cost. In addition, you have delivered excellent professional services in a timely fashion’ Yong Yuan Associate Director, Decision Science, Bristol-Myers Squibb